Super-resolved multiphoton microscopy with dual output ultrafast laser
Project Number7K25EB032864-02
Former Number1K25EB032864-01A1
Contact PI/Project LeaderCOTO HERNANDEZ, IVAN
Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
Project Summary/ Abstract
Nervous system disease may yield devastating impact on cognition, emotion, or sensorimotor function. Gene
delivery using adeno-associated virus (AAV) vectors has demonstrated immense potential for treatment of
congenital and acquired diseases impacting the central and peripheral nervous systems. Advancing
mechanistic understanding of vector uptake and trafficking within nervous system cells would inform viral
vector capsid design. Heretofore, visualizing viral vector cellular transduction in vivo has been hampered by a
lack of optimal means for resolving nanoscale particles in thick tissues. Imaging viral particles whose
dimensions are below the ~250 nm diffraction limit resolution of light microscopy is typically achieved using
electron microscopy, a resource-intensive technique incompatible with life. There is a critical need to develop
intravital imaging techniques that enable high-speed and deep nanoscale imaging of living systems. Two-
photon excitation (2PE) microscopy is a powerful technique for intravital imaging of the nervous system that
employs ultrafast near-infrared laser light capable of penetrating deep into tissues. Though the technique
enables intravital imaging of thick tissues, the achievable resolution and image quality of 2PE microscopy is
inadequate for study of nanoscale processes. 2PE microscopy may be paired with stimulated emission
depletion (STED) techniques to enable resolution of nanoscale fluorescent-tagged targets. To enhance
imaging depth and signal-to-background, 2PE may be achieved via spatiotemporal overlap of two ultrafast
lasers of different wavelengths in a process termed non-degenerate 2PE. Heretofore, wide dissemination of
2PE-STED and non-degenerate 2PE microscopy techniques have been hampered by the cost and complexity
associated with synchronization and alignment of two ultrafast laser sources. Herein, we propose to develop
efficient super-resolved multiphoton microscopy approaches to enhance spatiotemporal resolution and imaging
depth within living tissues by employing a single dual-output commercial ultrafast laser. Once developed, we
will employ these novel imaging platforms to study intracellular trafficking of single AAV particles within cells of
the murine nervous system. In Aim 1, the dual-output ultrafast laser will be utilized to achieve 2PE-STED
microscopy via pulsed depletion and employed to image AAV trafficking in cultured Schwann cells and primary
sensory neurons of murine dorsal root ganglia. In Aim 2, the dual-output ultrafast laser will be utilized to
achieve non-degenerate 2PE and paired with a continuous wave depletion beam for deep super-resolution
imaging of AAV trafficking in corneal Schwann cells and sensory neurons in live anesthetized mice. A liquid
lens will be employed to enhance volumetric imaging speed. If successful, this work carries potential to
advance understanding of viral vector transduction of nervous system cells by identifying intracellular trafficking
bottlenecks, while illustrating the potential of super-resolution 2PE microscopy techniques to advance
knowledge discovery in biomedicine.
Public Health Relevance Statement
Project Narrative
Gene delivery using adeno-associated virus vectors has tremendous potential as treatment for congenital and
acquired diseases of the nervous system. Understanding viral vector dynamics is key to optimizing drug design
and has been hampered by a lack of means to resolve nanoscale viral particles in living tissues. This proposal
seeks to develop efficient super-resolution imaging tools to improve imaging of adeno-associated viral vector
trafficking in live animal models to advance understanding of viral vector bgene delivery.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
073130411
UEI
FLJ7DQKLL226
Project Start Date
01-March-2023
Project End Date
28-February-2026
Budget Start Date
01-March-2024
Budget End Date
28-February-2025
Project Funding Information for 2024
Total Funding
$146,621
Direct Costs
$135,760
Indirect Costs
$10,861
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$146,621
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7K25EB032864-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7K25EB032864-02
Patents
No Patents information available for 7K25EB032864-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7K25EB032864-02
Clinical Studies
No Clinical Studies information available for 7K25EB032864-02
News and More
Related News Releases
No news release information available for 7K25EB032864-02
History
No Historical information available for 7K25EB032864-02
Similar Projects
No Similar Projects information available for 7K25EB032864-02